evenfolioETF Details
Invesco·Health·PSCH · Nasdaq
Invesco S&P SmallCap Health Care ETF (PSCH)
- Price
- $55.69
- —30 Oct 2026
- Assets
- $178.5M
- Total net assets
- Expense ratio
- 0.29%
- Category 1.00%
- Yield
- 0.00%
- Trailing distributions
- 1Y return
- 32.3%+3.5%
- Category 28.8%
- 3Y CAGR
- 16.9%-4.6%
- Category 21.5%
- 5Y CAGR
- -1.7%-5.8%
- Category 4.1%
Loading NAV history…
Invesco S&P SmallCap Health Care ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +7.0% | +4.3% | +24.0% | +26.4% | +32.3% | +16.9% | -1.7% | +9.7% | +12.3% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +3.4% | -5.6% | +1.0% | +6.0% | +3.5% | -4.6% | -5.8% | -1.2% | +0.7% |
Holdings
The 10 largest positions make up 34.9% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| GKOS | Glaukos Corp | 5.22% |
| PTGX | Protagonist Therapeutics Inc | 4.92% |
| TGTX | TG Therapeutics Inc | 4.27% |
| ALKS | Alkermes PLC | 3.66% |
| LGND | Ligand Pharmaceuticals Inc | 3.36% |
| PTCT | PTC Therapeutics Inc | 2.91% |
| TFX | Teleflex Inc | 2.86% |
| MMSI | Merit Medical Systems Inc | 2.77% |
| RDNT | RadNet Inc | 2.63% |
| ITGR | Integer Holdings Corp | 2.31% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 25.1
- P/B
- 2.9
- P/S
- 2.1
- P/CF
- 14.8
Sector allocation
Share of the equity the fund holds.
- Health care98.8%
- Financial services1.2%
Asset mix
- Stocks100.0%
- Cash0.0%
ETF details
- Issuer
- Invesco
- Category
- Equity · Health
- Ticker
- PSCH
- Exchange
- Nasdaq
- Inception
- 7 Apr 2010 (16.6 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.29% (category 1.00%)
- Holdings turnover
- 42% (category 51%)
- Distribution yield
- 0.00%
- Beta, 3 years
- 0.88
- Total net assets
- $178.5M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- BBP · Virtus Biotech ETFVirtus · $131.5M · ER 0.34%5Y 15.0%
- LFSC · F/M Emerald Life Sciences Innovation ETFEmerald Mutual Fund Advisers Trust · $123.4M · ER 0.54%
- IBBQ · Invesco Nasdaq Biotechnology ETFInvesco · $103.3M · ER 0.19%5Y 8.7%
- GNOM · Global X Genomics & Biotechnology ETFGlobal X Funds · $102.9M · ER 0.50%5Y -3.8%
- AGNG · Global X Aging Population ETFGlobal X Funds · $88.9M · ER 0.50%5Y 6.8%
- HTEC · ROBO Global Healthcare Technology and Innovation ETFRobo Global · $76.3M · ER 0.68%5Y -0.3%